Nasal mucosal IgA levels against SARS-CoV-2 and seasonal coronaviruses are low in children but boosted by reinfection
Open Access
- 3 September 2023
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 87 (5) , 403-412
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severityNature Communications, 2020
- IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administrationHuman Vaccines & Immunotherapeutics, 2018
- Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of AdultsThe Journal of Infectious Diseases, 2015
- Impaired Antibody-Mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial VirusAmerican Journal of Respiratory and Critical Care Medicine, 2015
- First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhoodBMC Infectious Diseases, 2013
- Human Coronavirus NL63 and 229E Seroconversion in ChildrenJournal of Clinical Microbiology, 2008
- Biological Functions of IgA2007
- In Vitro Comparison of the Biologic Activities of Monoclonal Monomeric IgA, Polymeric IgA, and Secretory IgAThe Journal of Immunology, 1998
- Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenzaVaccine, 1990
- Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infectionEpidemiology and Infection, 1985